Funding will accelerate development of manufactured pancreatic beta cells capable of restoring insulin production using Syntax’s Cellgorithm™ technology CHICAGO & NEW YORK, December 10, ...
Funding will accelerate development of manufactured pancreatic beta cells capable of restoring insulin production using Syntax’s Cellgorithm™ technology Syntax Bio, a synthetic biology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results